Pseudoprogression of a Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Anti-PD-1 Immunotherapy: A Case Report and Review of the Literature
Chemotherapy · 05.06.2026 · 1-6
DOI: 10.1159/000552926 ↗Kurz gefasst
Fallbericht in der Zeitschrift Chemotherapy, online erschienen am 05.06.2026. Verfasst von Ioannis M Koukourakis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Stereotactic Radiosurgery, 401 General Military Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Cutaneous Squamous Cell Carcinoma, Immune Checkpoint Inhibitors. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
Pseudoprogression during immunotherapy (IO) – defined as clinical documentation of tumor growth or new lesions during treatment with immune checkpoint inhibitors, followed by disease regression – has been reported in ≤10% of cases. Its incidence appears to be lower in cutaneous squamous cell carcinoma (cSCC) patients (1.5–4%). Case Presentation: We report a rare case of pseudoprogression of an advanced cSCC during IO (cemiplimab). Following initial surgery for a cSCC of the left auricular area, the tumor recurred and infiltrated the ear cartilage and external auditory meatus. At the time of administration of the second IO, the tumor had rapidly grown with a fulminant pattern and doubled in size. Treatment with IO continued, as per protocol, and by the third infusion appointment, the tumor had disappeared, and complete re-epithelialization of the auricular area was observed, confirming pseudoprogression. So far, the patient has received ten cycles of IO without experiencing toxicity, and there has been no sign of disease recurrence.
Conclusion
Awareness of potential pseudoprogression is crucial for clinicians managing advanced cSCC with cemiplimab.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology and Stereotactic Radiosurgery, 401 General Military Hospital, Athens, Greece.
- Department of Radiotherapy/Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
- Department of Radiotherapy/Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, targ@her.forthnet.gr.
Zitieren
APA
Koukourakis, I. M., Verigos, E. K., Verigos, K. E., & Koukourakis, M. I. (2026). Pseudoprogression of a Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Anti-PD-1 Immunotherapy: A Case Report and Review of the Literature. Chemotherapy, 1-6. https://doi.org/10.1159/000552926
Vancouver
Koukourakis IM, Verigos EK, Verigos KE, Koukourakis MI. Pseudoprogression of a Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Anti-PD-1 Immunotherapy: A Case Report and Review of the Literature. Chemotherapy. 2026:1-6. doi:10.1159/000552926
BibTeX
@article{Koukourakis2026,
author = {Koukourakis, Ioannis M and Verigos, Emmanouil K and Verigos, Kosmas E and Koukourakis, Michael I},
title = {Pseudoprogression of a Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Anti-PD-1 Immunotherapy: A Case Report and Review of the Literature},
journal = {Chemotherapy},
year = {2026},
pages = {1--6},
doi = {10.1159/000552926}
}
EUVIMED